UBS Group Analysts Give ABB (VTX:ABBN) a CHF 20.50 Price Target

Share on StockTwits

UBS Group set a CHF 20.50 target price on ABB (VTX:ABBN) in a research report released on Monday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other brokerages also recently issued reports on ABBN. Royal Bank of Canada set a CHF 21 price objective on ABB and gave the stock a neutral rating in a research report on Tuesday, August 6th. Jefferies Financial Group set a CHF 20 price objective on ABB and gave the stock a neutral rating in a research report on Thursday, July 25th. Kepler Capital Markets set a CHF 24 price target on ABB and gave the company a buy rating in a report on Wednesday, April 24th. JPMorgan Chase & Co. set a CHF 18 price target on ABB and gave the company a sell rating in a report on Thursday, July 25th. Finally, Deutsche Bank set a CHF 23 price target on ABB and gave the company a buy rating in a report on Friday, July 26th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the stock. ABB currently has an average rating of Hold and a consensus price target of CHF 22.81.

ABB has a 12-month low of CHF 21.65 and a 12-month high of CHF 27.24.

ABB Company Profile

ABB Ltd (ABB) is a holding company. The Company’s segments include Electrification Products, Robotics and Motion, Industrial Automation, Power Grids, and Corporate and Other. It operates through four divisions: Electrification Products, Robotics and Motion, Industrial Automation and Power Grids. It is engaged in serving customers in utilities, industry and transport and infrastructure.

Featured Article: When can a hold rating present a buying opportunity?

Analyst Recommendations for ABB (VTX:ABBN)

Receive News & Ratings for ABB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABB and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.